Lista de obras - J P Hubble - Dominio Público Uruguay

AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies

artículo científico publicado en 2012

Age at onset in two common neurodegenerative diseases is genetically controlled

artículo científico publicado en 2002

An open-label evaluation of the tolerability and safety of Stalevo (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-off

artículo científico publicado en 2004

Apolipoprotein E controls the risk and age at onset of Parkinson disease

artículo científico publicado en 2004

Apolipoprotein E genotypes in Parkinson's disease with and without dementia

scientific article published on 01 February 1995

Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease

artículo científico publicado en 2016

Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists ⬇️

artículo científico publicado el 1 de julio de 2003

Association of Single-Nucleotide Polymorphisms of the Tau Gene With Late-Onset Parkinson Disease ⬇️

artículo científico publicado el 14 de noviembre de 2001

Association study of Parkin gene polymorphisms with idiopathic Parkinson disease

artículo científico publicado en 2003

Benefits of COMT inhibitors in levodopa-treated parkinsonian patients: results of clinical trials.

artículo científico publicado en 2000

Botulinum toxin treatment of essential head tremor

scientific article published on 01 April 1995

Clinical experience with controlled-release carbidopa/levodopa in Parkinson's disease

artículo científico publicado en 1993

Clinical expression of essential tremor: Effects of gender and age ⬇️

artículo científico publicado el 1 de noviembre de 1997

Complete genomic screen in Parkinson disease: evidence for multiple genes.

artículo científico publicado en 2001

Deep brain stimulation for essential tremor

artículo científico publicado en 1996

Development and testing of the Parkinson's disease quality of life scale

artículo científico publicado en 2003

Differentiation of the dementias of Alzheimer's and Parkinson's disease with the dementia rating scale

artículo científico publicado en 1995

Does a long preclinical period occur in Parkinson's disease?

artículo científico publicado en 1991

Does a long preclinical period occur in Parkinson's disease?

scientific article published on 01 August 1991

Double-blind controlled study of methazolamide in the treatment of essential tremor

scientific article published on 01 May 1993

Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease

artículo científico publicado en 2004

Double‐blind controlled trial of gabapentin in essential tremor ⬇️

artículo científico publicado el 1 de mayo de 1998

EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's Disease

scientific article published on 01 January 2020

Early morning akinesia in Parkinson's disease: effect of standard carbidopa/levodopa and sustained-release carbidopa/levodopa.

scientific article published on 01 April 1996

Effects of selegiline dosing on motor fluctuations in Parkinson's disease

artículo científico publicado en 1993

Effects of thalamic deep brain stimulation based on tremor type and diagnosis

artículo científico publicado en 1997

Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study.

artículo científico publicado en 2002

Erythrocyte thiolmethyltransferase: another failed marker for Alzheimer's and Parkinson's diseases

artículo científico publicado en 1995

Essential tremor

artículo científico publicado en 1989

Gender differences in Parkinson's disease

artículo científico publicado en 1998

Gene-Toxin Interaction as a Putative Risk Factor for Parkinson’s Disease with Dementia ⬇️

artículo científico publicado el 1 de enero de 1998

Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease

artículo científico publicado en 2003

Genome-wide scan for Parkinson's disease: the GenePD Study

artículo científico publicado en 2001

Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease

artículo científico publicado en 2003

High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor.

artículo científico publicado en 1997

Immunoresistance in cervical dystonia patients after treatment with abobotulinumtoxinA

artículo científico publicado en 2012

Influence of demographic variables on the Dementia Rating Scale.

artículo científico publicado en 1995

Interactive video conferencing: a means of providing interim care to Parkinson's disease patients

artículo científico publicado en 1993

Is essential tremor benign? ⬇️

artículo científico publicado el 1 de diciembre de 1991

Levodopa therapy in Parkinson's disease

artículo científico publicado en 1990

Linear pharmacokinetic behavior of ropinirole during multiple dosing in patients with Parkinson's disease

artículo científico publicado en 2000

Long-term evaluation of deep brain stimulation of the thalamus

artículo científico publicado en 2006

Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease

artículo científico publicado en 2003

Motor Complications of Chronic Levodopa Therapy in Parkinsonʼs Disease ⬇️

artículo científico publicado el 1 de diciembre de 1997

Nocardia species as an etiologic agent in Parkinson's disease: serological testing in a case-control study

artículo científico publicado en 1995

Normal distribution of apolipoprotein E alleles in progressive supranuclear palsy

artículo científico publicado en 1996

PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study

artículo científico publicado en 2002

Parkin mutations and susceptibility alleles in late-onset Parkinson's disease

article

Personality and depression in Parkinson's disease

artículo científico publicado en 1993

Pharmacokinetic-pharmacodynamic crossover comparison of two levodopa extension strategies.

artículo científico publicado en 2009

Pramipexole in patients with early Parkinson's disease

artículo científico publicado en 1995

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial

artículo científico publicado en 2004

Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.

artículo científico publicado en 2003

Risk factors for Parkinson's disease

artículo científico publicado en 1993

Risk factors for dementia in Parkinson's disease: effect of education

artículo científico publicado en 1996

Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group

artículo científico publicado en 1997

TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial

artículo científico publicado en 2006

The effect of acetazolamide on essential tremor: An open-label trial ⬇️

artículo científico publicado el 1 de julio de 1992

The effect of deprenyl and levodopa on the progression of Parkinson's disease

artículo científico publicado en 1995

The effect of entacapone on homocysteine levels in Parkinson disease

artículo científico publicado en 2005

The influence of depression on cognition in Parkinson's disease: a pattern of impairment distinguishable from Alzheimer's disease

artículo científico publicado en 1995

The parkinsonian personality

artículo científico publicado en 1995

The α-synuclein gene is not a major risk factor in familial Parkinson disease

article

Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease

artículo científico publicado en 2000

Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's disease

scholarly article published in Movement Disorders

Vagus nerve stimulation for essential tremor: a pilot efficacy and safety trial

artículo científico publicado en 2003

Lista de obras de J P Hubble

AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies

Age at onset in two common neurodegenerative diseases is genetically controlled

An open-label evaluation of the tolerability and safety of Stalevo (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-off

Apolipoprotein E controls the risk and age at onset of Parkinson disease

Apolipoprotein E genotypes in Parkinson's disease with and without dementia

Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease

Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists ⬇️

Association of Single-Nucleotide Polymorphisms of the Tau Gene With Late-Onset Parkinson Disease ⬇️

Association study of Parkin gene polymorphisms with idiopathic Parkinson disease

Benefits of COMT inhibitors in levodopa-treated parkinsonian patients: results of clinical trials.

Botulinum toxin treatment of essential head tremor

Clinical experience with controlled-release carbidopa/levodopa in Parkinson's disease

Clinical expression of essential tremor: Effects of gender and age ⬇️

Complete genomic screen in Parkinson disease: evidence for multiple genes.

Deep brain stimulation for essential tremor

Development and testing of the Parkinson's disease quality of life scale

Differentiation of the dementias of Alzheimer's and Parkinson's disease with the dementia rating scale

Does a long preclinical period occur in Parkinson's disease?

Does a long preclinical period occur in Parkinson's disease?

Double-blind controlled study of methazolamide in the treatment of essential tremor

Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease

Double‐blind controlled trial of gabapentin in essential tremor ⬇️

EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's Disease

Early morning akinesia in Parkinson's disease: effect of standard carbidopa/levodopa and sustained-release carbidopa/levodopa.

Effects of selegiline dosing on motor fluctuations in Parkinson's disease

Effects of thalamic deep brain stimulation based on tremor type and diagnosis

Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study.

Erythrocyte thiolmethyltransferase: another failed marker for Alzheimer's and Parkinson's diseases

Essential tremor

Gender differences in Parkinson's disease

Gene-Toxin Interaction as a Putative Risk Factor for Parkinson’s Disease with Dementia ⬇️

Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease

Genome-wide scan for Parkinson's disease: the GenePD Study

Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease

High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor.

Immunoresistance in cervical dystonia patients after treatment with abobotulinumtoxinA

Influence of demographic variables on the Dementia Rating Scale.

Interactive video conferencing: a means of providing interim care to Parkinson's disease patients

Is essential tremor benign? ⬇️

Levodopa therapy in Parkinson's disease

Linear pharmacokinetic behavior of ropinirole during multiple dosing in patients with Parkinson's disease

Long-term evaluation of deep brain stimulation of the thalamus

Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease

Motor Complications of Chronic Levodopa Therapy in Parkinsonʼs Disease ⬇️

Nocardia species as an etiologic agent in Parkinson's disease: serological testing in a case-control study

Normal distribution of apolipoprotein E alleles in progressive supranuclear palsy

PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study

Parkin mutations and susceptibility alleles in late-onset Parkinson's disease

Personality and depression in Parkinson's disease

Pharmacokinetic-pharmacodynamic crossover comparison of two levodopa extension strategies.

Pramipexole in patients with early Parkinson's disease

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial

Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD.

Risk factors for Parkinson's disease

Risk factors for dementia in Parkinson's disease: effect of education

Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group

TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial

The effect of acetazolamide on essential tremor: An open-label trial ⬇️

The effect of deprenyl and levodopa on the progression of Parkinson's disease

The effect of entacapone on homocysteine levels in Parkinson disease

The influence of depression on cognition in Parkinson's disease: a pattern of impairment distinguishable from Alzheimer's disease

The parkinsonian personality

The α-synuclein gene is not a major risk factor in familial Parkinson disease

Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease

Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's disease

Vagus nerve stimulation for essential tremor: a pilot efficacy and safety trial